
Shiltrone 3mg Injection
Marketer
Shilpa Medicare Ltd
Salt Composition
Granisetron (3mg)
Overview Shiltrone 3mg Injection
Oncaspar 3mg Injection is an antiemetic medication frequently used to manage nausea and vomiting resulting from surgery, chemotherapy, or radiation therapy. Oncaspar 3mg Injection does not alleviate other cancer treatment side effects. Administration requires healthcare professional oversight, following the physician's prescribed regimen. Continued injections are crucial until medically deemed safe to discontinue; subsequent oral medication may be prescribed. Common side effects include injection site discomfort, headache, bowel irregularities (constipation or diarrhea), and fatigue. These typically subside upon cessation of treatment; however, persistent or bothersome symptoms warrant discussion with your physician for potential management strategies. Prior to use, inform your doctor of any pre-existing heart or liver conditions, gastrointestinal obstructions, and all current medications, particularly those for epilepsy, cardiac issues, cancer, or depression, as interactions may occur. Pregnant or breastfeeding individuals should consult their healthcare provider.
Uses of Shiltrone 3mg Injection
Chemotherapy-induced emesis
Major Benefits of Shiltrone 3mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Shiltrone 3mg Injection:
- Injection site pain
- Constipation
- Diarrhea
- Headache
- Weakness
- Insomnia (difficulty in sleeping)
How to use Shiltrone 3mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Shiltrone 3mg Injection works:
This injectable antiemetic, Shiltrone 3mg, counteracts chemotherapy- or surgery-induced nausea and vomiting. Its mechanism involves inhibiting the activity of serotonin, a neurotransmitter in the brain responsible for triggering these symptoms.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Shiltrone 3mg Injection may pose unknown risks. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The injectable form of Shiltrone, at a 3mg dose, is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Shiltrone 3mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingSAFE
Administration of Shiltrone 3mg Injection typically does not impair driving capabilities.
KidneySAFE IF PRESCRIBED
Use of the 3mg Shiltrone injection in patients with kidney disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Shiltrone 3mg Injection in individuals with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Shiltrone 3mg Injection :
Should you forget a Shiltrone 3mg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Shiltrone 3mg Injection
| Label | Value |
|---|---|
| Chemical Type | Indazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavioral Class | 5-HT3 receptor blockers |
